LURASIDONE HYDROCHLORIDE | A208058 | HERITAGE PHARMA LABS INC DBA AVET PHARMACEUTICALS LABS INC
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
SUMITOMO DAINIPPON PHARMA CO., LTD. et al v. EMCURE PHARMACEUTICALS LIMITED et al 1 patentANDA 208058lurasidone hydrochloride | D.N.J. | 2015-01-14 | Terminated 2017-02-28 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
Highest NADAC/Unit
$0.4889
per ea
Lowest NADAC/Unit
$0.1348
per ea
Brand NDCs
0
Generic NDCs
5
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 23155089103LURASIDONE HCL 120 MG TABLET | $0.4889 | EA | Generic | — | 2026-06-17 |
| 23155089003LURASIDONE HCL 80 MG TABLET | $0.3366 | EA | Generic | — | 2026-06-17 |
| 23155088903LURASIDONE HCL 60 MG TABLET | $0.3018 | EA | Generic | — | 2026-06-17 |
| 23155088803LURASIDONE HCL 40 MG TABLET | $0.2232 | EA | Generic | — | 2026-06-17 |
| 23155088703LURASIDONE HCL 20 MG TABLET | $0.1348 | EA | Generic | — | 2026-06-17 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.